stockrow
Friday 6 November 2026
Export ICLR’s income statement to Excel — free account
ICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
201.62
1.49
−0.73%
Follow ICLR
Alert me
ICON PLC (ICLR) EBITDA
ICON PLC's EBITDA for fiscal 2025 was $825.8M, down 45.7% from $1.5B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.1B. Over the past ten years it has ranged from $339.3M (fiscal 2015) to $1.5B (fiscal 2023); the current reading is higher than 73% of that period. ICON PLC ranks 10th of 49 Diagnostics & Research companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $825.8M | (45.70%) |
| FY2024 | $1.5B | (1.38%) |
| FY2023 | $1.5B | 13.00% |
| FY2022 | $1.4B | 96.79% |
| FY2021 | $693.5M | 51.55% |
| FY2020 | $457.6M | (12.88%) |
| FY2019 | $525.3M | 19.59% |
| FY2018 | $439.2M | 9.92% |
| FY2017 | $399.6M | 7.64% |
| FY2016 | $371.2M | 9.42% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $293.3M | 28.29% |
| Jun 2026 | $228.6M | (13.43%) |
| Mar 2026 | $264.1M | (11.43%) |
| Dec 2025 | $298.1M | — |
| 43 more quarters | Free account |
Against its own ten years
Low $339.3M
High $1.5B
Ten-year median
$525.3M
Current reading's percentile
73
EBITDA against peers
| Company | EBITDA |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $2.3B |
| LH Labcorp Holdings Inc. compare | $2.2B |
| ILMN Illumina, Inc. compare | $1.2B |
| ICLR ICON PLC | $1.1B |
| RVTY Revvity Inc. compare | $775.8M |
| QGEN QIAGEN N.V. compare | $651.0M |
| MEDP Medpace Holdings, Inc. compare | $634.5M |
| CRL Charles River Laboratories International, Inc. compare | $553.0M |
| GH Guardant Health, Inc. compare | −$444.9M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement